Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prednisolone Versus Colchicine for Acute Gout in Primary Care: statistical analysis plan for the pragmatic, multicenter, randomized, and double-blinded COPAGO non-inferiority trial.
Richter A, Truthmann J, Hummers E, Pereira JFM, Gágyor I, Schuster F, Witte A, Böhm S, Greser A, Kamin P, Stracke S, Dörr M, Bülow R, Engeli S, Chenot JF, Ittermann T. Richter A, et al. Among authors: engeli s. Trials. 2024 Apr 3;25(1):229. doi: 10.1186/s13063-024-08066-0. Trials. 2024. PMID: 38570873 Free PMC article. Clinical Trial.
Prescriptions for Potentially Inappropriate Medication (PIM).
Wohlgemuth A, Michalowsky B, Hoffmann W, Platen M, Engeli S, Wucherer D, Ittermann T. Wohlgemuth A, et al. Among authors: engeli s. Dtsch Arztebl Int. 2024 Jan 12;121(1):25-26. doi: 10.3238/arztebl.m2023.0181. Dtsch Arztebl Int. 2024. PMID: 38386944 Free PMC article. No abstract available.
Prednisolone Versus Colchicine for Acute Gout in Primary Care (COPAGO): protocol for a two-arm multicentre, pragmatic, prospective, randomized, double-blind, controlled clinical trial of prednisolone and colchicine for non-inferiority with a parallel group design.
Truthmann J, Freyer Martins Pereira J, Richter A, Schuster F, Witte A, Böhm S, Greser A, Kamin P, Stracke S, Dörr M, Bülow R, Engeli S, Gágyor I, Hummers E, Chenot JF. Truthmann J, et al. Among authors: engeli s. Trials. 2023 Oct 5;24(1):643. doi: 10.1186/s13063-023-07666-6. Trials. 2023. PMID: 37798801 Free PMC article.
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025.
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Luedde T, Roden M, Schattenberg J, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators:. Roeb E, et al. Z Gastroenterol. 2022 Sep;60(9):1346-1421. doi: 10.1055/a-1880-2283. Epub 2022 Sep 13. Z Gastroenterol. 2022. PMID: 36100202 Free article. German. No abstract available.
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
Schäfer E, Scheer C, Saljé K, Fritz A, Kohlmann T, Hübner NO, Napp M, Fiedler-Lacombe L, Stahl D, Rauch B, Nauck M, Völker U, Felix S, Lucchese G, Flöel A, Engeli S, Hoffmann W, Hahnenkamp K, Tzvetkov MV. Schäfer E, et al. Among authors: engeli s. Sci Rep. 2022 May 4;12(1):7249. doi: 10.1038/s41598-022-11103-0. Sci Rep. 2022. PMID: 35508524 Free PMC article.
165 results